Nashville, TN, United States of America

Richard Williams

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Bangor North Down, IE (2012)
  • Bangor, GB (2013)
  • Bangor North Down, GB (2013)
  • Nashville, TN (US) (2007 - 2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Discovering the Innovations of Richard Williams: A Pioneer in Neurological Research

Introduction

Richard Williams, based in Nashville, TN, is a prolific inventor in the field of neurological research. With a remarkable total of nine patents to his name, he has dedicated his career to developing compounds that can significantly impact the treatment of neurological and psychiatric disorders. Richard's latest innovations reflect his commitment to advancing medical science and improving the quality of life for those suffering from these conditions.

Latest Patents

Two of Richard Williams' latest patents illustrate his innovative spirit and expertise. The first, titled "Benzamide mGluR5 positive allosteric modulators and methods of making and using same," describes several novel compounds that demonstrate promise as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5). These compounds include various derivatives such as phenylethynylbenzamide and cycloalkylethynylbenzamide, among others. The synthetic methods for these compounds not only provide researchers with new tools but also pave the way for pharmaceutical compositions aimed at treating neurological disorders associated with glutamate dysfunction.

The second patent, "Bicyclic GlyT1 inhibitors and methods of making and using same," focuses on compounds that can inhibit glycine type 1 transporter (GlyT1) activity. This advancement opens new avenues for therapeutic strategies targeting disorders related to GlyT1 activity. Richard’s innovative approaches address critical needs in the medical field by providing new methods and compositions for treating complex disorders.

Career Highlights

Richard Williams has made significant contributions through his roles at esteemed organizations, including Vanderbilt University and Cardax Pharmaceuticals, Inc. His work in these institutions has been instrumental in the research and development of new therapeutic compounds, showcasing his dedication to scientific advancement and innovation in pharmacology.

Collaborations

Throughout his career, Richard has collaborated with notable colleagues such as P Jeffrey Conn and Craig William Lindsley. These partnerships highlight the collaborative nature of scientific research, where sharing knowledge and expertise accelerates the development of groundbreaking therapies.

Conclusion

In summary, Richard Williams stands out as a key inventor in the realm of neurological research, with his nine patents demonstrating his profound impact on the field. His innovative compounds have the potential to revolutionize treatment methods for various neurological and psychiatric disorders. As research continues to evolve, Richard’s contributions will undoubtedly play a critical role in shaping future therapies and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…